BJP Try Psychiatric Bulletin Online
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Versiani, M.
Right arrow Articles by Amrein, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Versiani, M.
Right arrow Articles by Amrein, R.

The British Journal of Psychiatry 161: 353-360 (1992)
© 1992 The Royal College of Psychiatrists

Pharmacotherapy of social phobia. A controlled study with moclobemide and phenelzine

M Versiani, AE Nardi, FD Mundim, AB Alves, MR Liebowitz and R Amrein

In a double-blind, parallel group trial, 78 subjects with social phobia received moclobemide (a new reversible inhibitor of monoamine oxidase A) phenelzine, or placebo. After eight weeks, both active drugs- phenelzine somewhat more than moclobemide--were clinically and statistically significantly more effective than placebo, as assessed by rating scales. There was some further improvement between weeks 8 and 16, particularly in the moclobemide group; at week 16, 82% of the moclobemide and 91% of the phenelzine-treated patients were almost asymptomatic. Moclobemide was, however, much better tolerated than phenelzine. Patients withdrawn from active drugs had relapsed by week 24, providing additional support for the efficacy of the active drugs.


This article has been cited by other articles:


Home page
 Arch Gen PsychiatryHome page
M. R. Liebowitz, A. J. Gelenberg, and D. Munjack
Venlafaxine Extended Release vs Placebo and Paroxetine in Social Anxiety Disorder
Arch Gen Psychiatry, February 1, 2005; 62(2): 190 - 198.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. PsychiatryHome page
T. T. HAUG, S. BLOMHOFF, K. HELLSTROM, I. HOLME, M. HUMBLE, H. P. MADSBU, and J. E. WOLD
Exposure therapy and sertraline in social phobia: I-year follow-up of a randomised controlled trial
The British Journal of Psychiatry, April 1, 2003; 182(4): 312 - 318.
[Abstract] [Full Text] [PDF]

Home page
 Adv. Psychiatr. Treat.Home page
A. Lingford-Hughes, J. Potokar, and D. Nutt
Treating anxiety complicated by substance misuse
Advan. Psychiatr. Treat., March 1, 2002; 8(2): 107 - 116.
[Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
M. A. Van Ameringen, R. M. Lane, J. R. Walker, R. C. Bowen, P. R. Chokka, E. M. Goldner, D. G. Johnston, Y.-J. Lavallee, S. Nandy, J. C. Pecknold, et al.
Sertraline Treatment of Generalized Social Phobia: A 20-Week, Double-Blind, Placebo-Controlled Study
Am J Psychiatry, February 1, 2001; 158(2): 275 - 281.
[Abstract] [Full Text]

Home page
 Fam PractHome page
T. T. Haug, K. Hellstrom, S. Blomhoff, M. Humble, H.-P. Madsbu, and J. E. Wold
The treatment of social phobia in general practice. Is exposure therapy feasible?
Fam. Pract., April 1, 2000; 17(2): 114 - 118.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
M. B. Stein, A. J. Fyer, J. R.T. Davidson, M. H. Pollack, and B. Wiita
Fluvoxamine Treatment of Social Phobia (Social Anxiety Disorder): A Double-Blind, Placebo-Controlled Study
Am J Psychiatry, May 1, 1999; 156(5): 756 - 760.
[Abstract] [Full Text]

Home page
 Arch Gen PsychiatryHome page
R. G. Heimberg, M. R. Liebowitz, D. A. Hope, F. R. Schneier, C. S. Holt, L. A. Welkowitz, H. R. Juster, R. Campeas, M. A. Bruch, M. Cloitre, et al.
Cognitive Behavioral Group Therapy vs Phenelzine Therapy for Social Phobia: 12-Week Outcome
Arch Gen Psychiatry, December 1, 1998; 55(12): 1133 - 1141.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals
Copyright © 1992 The Royal College of Psychiatrists.